PL355298A1 - Dermatological preparation for the treatment of skin damage - Google Patents

Dermatological preparation for the treatment of skin damage

Info

Publication number
PL355298A1
PL355298A1 PL02355298A PL35529802A PL355298A1 PL 355298 A1 PL355298 A1 PL 355298A1 PL 02355298 A PL02355298 A PL 02355298A PL 35529802 A PL35529802 A PL 35529802A PL 355298 A1 PL355298 A1 PL 355298A1
Authority
PL
Poland
Prior art keywords
treatment
skin damage
dermatological preparation
dermatological
preparation
Prior art date
Application number
PL02355298A
Other languages
Polish (pl)
Inventor
Jerzy Maslanky
Original Assignee
DERMAPHYT Sp.z o.o.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DERMAPHYT Sp.z o.o. filed Critical DERMAPHYT Sp.z o.o.
Priority to PL02355298A priority Critical patent/PL355298A1/en
Priority to PCT/PL2002/000105 priority patent/WO2004022034A1/en
Priority to AU2002368219A priority patent/AU2002368219A1/en
Publication of PL355298A1 publication Critical patent/PL355298A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/55—Linaceae (Flax family), e.g. Linum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Dispersion Chemistry (AREA)
  • Insects & Arthropods (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Husbandry (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
PL02355298A 2002-08-01 2002-08-01 Dermatological preparation for the treatment of skin damage PL355298A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PL02355298A PL355298A1 (en) 2002-08-01 2002-08-01 Dermatological preparation for the treatment of skin damage
PCT/PL2002/000105 WO2004022034A1 (en) 2002-08-01 2002-12-18 Dermatological preparation for the treatment of skin lesions
AU2002368219A AU2002368219A1 (en) 2002-08-01 2002-12-18 Dermatological preparation for the treatment of skin lesions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL02355298A PL355298A1 (en) 2002-08-01 2002-08-01 Dermatological preparation for the treatment of skin damage

Publications (1)

Publication Number Publication Date
PL355298A1 true PL355298A1 (en) 2004-02-09

Family

ID=31974081

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02355298A PL355298A1 (en) 2002-08-01 2002-08-01 Dermatological preparation for the treatment of skin damage

Country Status (3)

Country Link
AU (1) AU2002368219A1 (en)
PL (1) PL355298A1 (en)
WO (1) WO2004022034A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263580B2 (en) 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
JP5612263B2 (en) * 2005-06-01 2014-10-22 スティーフェル リサーチ オーストラリア ピーティーワイ リミテッド Vitamin preparation
ITTO20080584A1 (en) * 2008-07-29 2010-01-30 Chiara Cesano COMPOSITION FOR THE REGENERATION OF SKIN FABRIC AND SUBCUTANEOUS SUBCUTANEOUS, RELATED PRODUCTS AND USES
GB0902040D0 (en) 2009-02-06 2009-03-11 Seeds Lp Composition for treatment of skin
PL228642B1 (en) * 2014-12-06 2018-04-30 Peszke Jerzy Przemyslaw Propolis-silver formulation accelerating soft tissue regeneration and method for obtaining it
WO2017146603A1 (en) * 2016-02-24 2017-08-31 Arcasiu Nicolae Pharmaceutical composition for the treatment of burns, use, and method of treatment
GR1009068B (en) * 2016-05-09 2017-07-05 Πετρος Παναγιωτη Παναγιωτου Therapeutical spayaing healing formulation acting as a bandage for decubitus ulcers
US10888590B2 (en) * 2017-07-21 2021-01-12 MatrixMed Inc. Medicated propolis oil composition
US11253467B2 (en) * 2018-12-03 2022-02-22 Slc Skin Llc. Wrinkle treatment
CN111420024B (en) * 2020-04-07 2023-10-03 中国科学院深圳先进技术研究院 Application of bacillus phthalein A in preparing medicament for preventing and treating coronavirus
US11951199B1 (en) 2020-08-25 2024-04-09 Rivercrest, LLC Personal skincare product

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU203668B (en) * 1990-04-03 1991-09-30 Tamas Angeli Cosmetic containing medicinal plants and process for producing composition against psoriasis
RO109503B1 (en) * 1992-02-17 1995-03-30 Constantin Nistor Anti sun cream
RO107087B1 (en) * 1992-03-04 1997-04-30 Manzatu Ioan Therapeutical ointment for wounds and burns treatment
DE19615293A1 (en) * 1996-04-18 1997-10-23 Johann Dibart Propolis skin disorder salve
DE19904801A1 (en) * 1999-02-05 2000-08-10 Klossner Axel Agent containing urea, sulfur and Calendula extract, useful for topical treatment of skin disorders, especially neurodermatitis
HU227318B1 (en) * 2000-03-08 2011-03-28 Tibor Bodnar Cosmetical and dematological composition for treating, grooming of psoric skin and scalp
AU2002241416A1 (en) * 2001-03-27 2002-10-08 Dorian Owoc Dermatological agent for the treatment of skin trauma, especially in burn conditions

Also Published As

Publication number Publication date
WO2004022034A1 (en) 2004-03-18
AU2002368219A1 (en) 2004-03-29

Similar Documents

Publication Publication Date Title
HUS1500048I1 (en) Local formulation of Ivermectin for the treatment of dermatological conditions
EP1641378A4 (en) Methods and devices for the treatment of skin lesions
PT1485127E (en) ADMINISTRATION OF AGENTS FOR THE TREATMENT OF INFLAMMATION
NO20052894D0 (en) 4-tetrazolyl-4-phenylpiperidine derivatives for the treatment of pain
EP1530449A4 (en) ARTIFICIAL HORN SKIN
CY2018006I1 (en) THERAPEUTIC FORMULATION OF CLADRIVINE FOR THE THERAPEUTIC TREATMENT OF PLAQUE STICHERONE
DE60304102D1 (en) Skin cleansing composition
DE60311298D1 (en) SCALP TREATMENT
ZA200507346B (en) Topical formulation of ivermectin for the treatment of dermatological conditions
ITMO20010008A0 (en) DEVICE FOR SKIN TREATMENTS
DE60221143D1 (en) BRUSTEINLAGE INCLUDING SKIN CARE
DE60223576D1 (en) SKIN TREATMENT COMPOSITION
DE60335019D1 (en) TOPICAL SKIN PREPARATIONS
ATE389742T1 (en) TISSUE TREATMENT PRODUCTS
PL355298A1 (en) Dermatological preparation for the treatment of skin damage
DK1553950T3 (en) Therapeutic treatment
DE60222664D1 (en) SKIN TREATMENT AGENT
DE602004000627D1 (en) Skin cleanser
NO20050689L (en) Therapeutic use
DE60312434D1 (en) Hair treatments
DE112004002142D2 (en) skin cream
GB0311815D0 (en) Skin treatments
IS7902A (en) Anti-skincare composition for skin care
GB0311816D0 (en) Skin treatments
ITRM20020307A0 (en) EQUIPMENT FOR THE TREATMENT OF SKIN LESIONS, AND RELATED METHOD.